The variant genotype carriers had significantly lower serum MEG3 expression (Fig. 3), consistent with prior reports of downregulation of MEG3 expression in asthma patients and providing biological explanation for the observed associations between variant genotypes and increased asthma risks. This evidence concerns the gene MEG3 and asthma.